Lean & Sculpt Pack
This carefully designed research peptide bundle combines the potent effects of Tirzepatide, Cagrilintide, and AOD9604, targeting multiple aspects of metabolic health and fat loss. Each peptide offers unique benefits for fat regulation, appetite suppression, and metabolic pathways, making this pack an ideal solution for comprehensive research into body composition and fat metabolism.
What’s Included in the Pack?
Tirzepatide Sodium Overview
Tirzepatide sodium, a peptide for treating type 2 diabetes, functions by mimicking the effects of incretin hormones GLP-1 and GIP. These hormones stimulate insulin release, reduce glucagon secretion, and slow gastric emptying. Used for improving blood sugar control in adults with type 2 diabetes, Tirzepatide also aids in weight loss. Administered via subcutaneous injection, it represents a significant advancement in type 2 diabetes management with its dual-action mechanism.
Product Details
- Amino Acid Sequence: YE-Aib-GTFSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS
- Note: Aib is a non-coded (non-proteinogenic) amino acid – H₂H-C(CH₃)₂-COOH
- Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular Weight: 4813.527 g/mol
- PubChem CID: 156588324
- CAS Number: 2023788-19-2
Research Highlights
- Blood Glucose Control: Tirzepatide effectively regulates blood glucose levels through dual agonism of GIP and GLP-1 receptors, crucial for insulin secretion and post-meal blood sugar management.
- Cardiovascular Benefits: Demonstrates the ability to improve cardiovascular health by lowering blood pressure and reducing levels of LDL cholesterol and triglycerides, suggesting a broader role in metabolic health beyond diabetes control.
Important Notices:
- This product is sold for scientific research purposes only.
- Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
- The quantity on the label refers to the total amount of product inside each vial.
- Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
- Vial appearance, label, seal, and cap colors may vary from product photos.
Cagrilintide Overview
Cagrilintide is an amylin analogue that targets appetite suppression and fat metabolism. Amylin is a hormone co-secreted with insulin that plays a significant role in regulating satiety and glucose control. Cagrilintide’s effects on reducing appetite and fat accumulation make it a promising peptide for body weight regulation and metabolic research.
Product Details
- Amino Acid Sequence: H-Asn-Thr-Asp-Pro-Val-Leu-Leu-Ser-Thr-Lys-Thr-Asn-Gly-Asn-Cys
- Molecular Formula: C₆₄H₉₉N₂₃O₁₉S₄
- Molecular Weight: 1471.67 g/mol
- CAS Number: 203710-84-9
Research Highlights
- Appetite Suppression: Cagrilintide mimics the effects of amylin to reduce hunger and caloric intake, supporting studies on obesity and fat regulation.
- Fat Metabolism: Demonstrates the ability to inhibit fat accumulation and enhance lipid metabolism, making it a key player in fat loss research.
Important Notices:
- This product is sold for scientific research purposes only.
- Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
- The quantity on the label refers to the total amount of product inside each vial.
AOD9604 Overview
AOD9604 is a modified fragment of human growth hormone (HGH) specifically developed to combat obesity and related metabolic issues. AOD9604 works by stimulating the breakdown of fat (lipolysis) and inhibiting the formation of new fat tissue (lipogenesis). Unlike traditional HGH, AOD9604 does not affect insulin levels or growth, making it a targeted peptide for fat loss research.
Product Details
- Sequence: H-Tyr-His-Gly-Phe-Met-Arg-D-Arg-Lys-Tyr-Ser-Val-Gly-Ser-Leu-Gln-OH
- Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂
- Molecular Weight: 1815.08 g/mol
- CAS Number: 221231-10-3
- PubChem CID: 70685657
Research Highlights
- Fat Loss and Lipid Metabolism: AOD9604 enhances fat burning and inhibits the formation of new fat cells, making it a promising peptide for weight management research.
- Safety and Tolerance: In clinical trials, AOD9604 has demonstrated good tolerance and safety, with no negative impact on insulin levels or blood sugar regulation.
Important Notices:
- This product is sold for scientific research purposes only.
- Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
- Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes, and needles to draw from the vials.
Why This Pack is Exceptional
This pack combines the powerful effects of Tirzepatide, Cagrilintide, and AOD9604 to target various metabolic pathways in weight loss and fat metabolism research. By combining these three peptides, researchers can explore the synergistic benefits of glucose control, appetite suppression, and fat breakdown for a comprehensive approach to body composition studies. Whether you’re investigating fat reduction or metabolic health, this pack offers a robust solution for advanced research.
